Published in Graefes Arch Clin Exp Ophthalmol on August 01, 2004
Update on the mechanism of action of topical prostaglandins for intraocular pressure reduction. Surv Ophthalmol (2008) 1.94
Clinical utility and differential effects of prostaglandin analogs in the management of raised intraocular pressure and ocular hypertension. Clin Ophthalmol (2010) 1.45
Mechanism of action of bimatoprost, latanoprost, and travoprost in healthy subjects. A crossover study. Ophthalmology (2008) 1.27
In vivo assessment of aqueous humor dynamics upon chronic ocular hypertension and hypotensive drug treatment using gadolinium-enhanced MRI. Invest Ophthalmol Vis Sci (2014) 0.90
Prostaglandin pathway gene therapy for sustained reduction of intraocular pressure. Mol Ther (2009) 0.88
Latanoprost Stimulates Ocular Lymphatic Drainage: An In Vivo Nanotracer Study. Transl Vis Sci Technol (2013) 0.86
The impact of intraocular pressure reduction on retinal ganglion cell function measured using pattern electroretinogram in eyes receiving latanoprost 0.005% versus placebo. Vision Res (2010) 0.78
A 4-week, dose-ranging study comparing the efficacy, safety and tolerability of latanoprost 75, 100 and 125 μg/mL to latanoprost 50 μg/mL (xalatan) in the treatment of primary open-angle glaucoma and ocular hypertension. BMC Ophthalmol (2012) 0.78
Latanoprost-induced changes in rat intraocular pressure: direct or indirect? J Ocul Pharmacol Ther (2008) 0.76
Tonographic method for measuring the facility and rate of aqueous flow in human eyes. Arch Ophthal (1950) 5.13
Clinical measurements of aqueous outflow. AMA Arch Ophthalmol (1951) 2.25
Effects of PhXA41, a new prostaglandin F2 alpha analog, on aqueous humor dynamics in human eyes. Ophthalmology (1993) 2.10
Flow of aqueous humor in humans [The Friedenwald Lecture]. Invest Ophthalmol Vis Sci (1991) 1.61
The regulation of trabecular meshwork and ciliary muscle contractility. Prog Retin Eye Res (2000) 1.52
Aqueous humor dynamics in the aging human eye. Am J Ophthalmol (1999) 1.44
Studies on the response of the transplanted kidney and the transplanted adrenal gland to thoracic inferior vena caval constriction. J Clin Invest (1961) 1.39
The effects on aqueous dynamics of PhXA41, a new prostaglandin F2 alpha analogue, after topical application in normal and ocular hypertensive human eyes. Arch Ophthalmol (1993) 1.35
Prostaglandin F2 alpha-isopropylester eye drops: effects in normal human eyes. Br J Ophthalmol (1989) 1.32
Increased uveoscleral outflow as a possible mechanism of ocular hypotension caused by prostaglandin F2 alpha-1-isopropylester in the cynomolgus monkey. Exp Eye Res (1989) 1.31
Prostaglandin F2 alpha increases uveoscleral outflow in the cynomolgus monkey. Exp Eye Res (1989) 1.27
Aqueous outflow pathway in normal and glaucomatous eyes. Br J Ophthalmol (1972) 1.20
Morphological study of the anterior segment of cynomolgus monkey eyes following treatment with prostaglandin F2 alpha. Exp Eye Res (1988) 1.19
Maintained reduction of intraocular pressure by prostaglandin F2 alpha-1-isopropyl ester applied in multiple doses in ocular hypertensive and glaucoma patients. Ophthalmology (1989) 1.03
Effects of topical PGF2 alpha on aqueous humor dynamics in cynomolgus monkeys. Curr Eye Res (1987) 1.03
Multiple dosing of prostaglandin F2 alpha or epinephrine on cynomolgus monkey eyes. I. Aqueous humor dynamics. Invest Ophthalmol Vis Sci (1987) 1.02
Effect of prostaglandin F2 alpha on aqueous humor dynamics of rabbit, cat, and monkey. Invest Ophthalmol Vis Sci (1984) 1.02
The effect of prostaglandin F2 alpha on trabecular outflow facility in cynomolgus monkeys. Exp Eye Res (1990) 1.00
Prostaglandin F2 alpha receptors in the human trabecular meshwork. Invest Ophthalmol Vis Sci (1998) 0.97
Uveoscleral aqueous outflow in the rhesus monkey: importance of uveal reabsorption. Invest Ophthalmol Vis Sci (1977) 0.94
Interaction of PhXA41, a new prostaglandin analogue, with pilocarpine. A study on patients with elevated intraocular pressure. Arch Ophthalmol (1993) 0.93
Effects of intracamerally infused prostaglandins on outflow facility in cynomolgus monkey eyes with intact or retrodisplaced ciliary muscle. Exp Eye Res (1986) 0.87
[Electron microscopy and immunohistochemical studies of the intraocular pressure lowering effect of prostaglandin F2 alpha]. Fortschr Ophthalmol (1990) 0.85
Uveoscleral drainage of aqueous humour. Exp Eye Res (1977) 0.79
Acetazolamide and symptomatic metabolic acidosis in mild renal failure. Br Med J (Clin Res Ed) (1982) 0.77
Multiple dosing of prostaglandin F2 alpha or epinephrine on cynomolgus monkey eyes. III. Histopathology. Invest Ophthalmol Vis Sci (1988) 0.75
Epithelial-Mesenchymal Transition (EMT)-Related Cytokines in the Aqueous Humor of Phakic and Pseudophakic Fuchs' Dystrophy Eyes. Invest Ophthalmol Vis Sci (2015) 2.04
Latanoprost stimulates secretion of matrix metalloproteinases in tenon fibroblasts both in vitro and in vivo. Invest Ophthalmol Vis Sci (2003) 1.04
Measurement of adherence to brimonidine therapy for glaucoma using electronic monitoring. J Glaucoma (2011) 0.94
A new rebound tonometer for home monitoring of intraocular pressure. Graefes Arch Clin Exp Ophthalmol (2011) 0.90
The effect of previous surgery and topical eye drops for primary open-angle glaucoma on cytokine expression in aqueous humor. Graefes Arch Clin Exp Ophthalmol (2014) 0.90
Retrospective analysis of the success and safety of Gold Micro Shunt Implantation in glaucoma. BMC Ophthalmol (2013) 0.87
The short-term effect of latanoprost on intraocular pressure and pulsatile ocular blood flow. Acta Ophthalmol Scand (2002) 0.86
Interobserver variability in confocal optic nerve analysis (HRT). Int Ophthalmol (2007) 0.86
The neuroprotective potential of Rho-kinase inhibition in promoting cell survival and reducing reactive gliosis in response to hypoxia in isolated bovine retina. Cell Physiol Biochem (2013) 0.83
Synergistic effects of combined cytotoxic and apoptosis-inducing drugs on Tenon's capsule fibroblasts in vitro and in vivo. Graefes Arch Clin Exp Ophthalmol (2007) 0.82
Anterior chamber aqueous flare is a strong predictor for proliferative vitreoretinopathy in patients with rhegmatogenous retinal detachment. Retina (2012) 0.82
Modelling ocular pharmacokinetics of fluorescein administered as lyophilisate or conventional eye drops. Eur J Clin Pharmacol (2008) 0.79
Characteristics of iris and retinal pigment epithelial cells cultured on collagen type I membranes. Curr Eye Res (2006) 0.79
Electronic compliance monitoring of topical treatment after ophthalmic surgery. Int Ophthalmol (2010) 0.78
Adherence with brimonidine in patients with glaucoma aware and not aware of electronic monitoring. Acta Ophthalmol (2010) 0.78
Tolerability and safety of two new preservative-free tear film substitutes. Cornea (2002) 0.77
Vitreous treatment of cultured human RPE cells results in differential expression of 10 new genes. Invest Ophthalmol Vis Sci (2002) 0.77
The state of being noninferior. Ophthalmology (2006) 0.75
Author Response: Transforming Growth Factor Beta Switch in Aqueous Humor of Patients With Fuchs' Endothelial Corneal Dystrophy. Invest Ophthalmol Vis Sci (2016) 0.75
Erratum. Latanoprost Stimulates Secretion of Matrix Metalloproteinases in Tenon Fibroblasts Both In Vitro and In Vivo. Invest Ophthalmol Vis Sci (2015) 0.75
The ophthalmic lyophilisate carrier system (OLCS): development of a novel dosage form, freeze-drying technique, and in vitro quality control tests. Eur J Pharm Biopharm (2004) 0.75
Photodynamic therapy for wound-healing modulation in pterygium surgery. A clinical pilot study. Graefes Arch Clin Exp Ophthalmol (2005) 0.75
[Drug therapy and monitoring of glaucoma]. Ophthalmologe (2013) 0.75